(Q36953255)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17899020%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Animal models of Parkinson's disease and L-dopa induced dyskinesia: how close are we to the clinic? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17899020%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17899020%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Stephen Dunnett

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17899020%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Emma Lane

series ordinal

1

1 reference

17 August 2017

Stephen Dunnett

series ordinal

2

1 reference

17 August 2017

25 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17899020%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17899020%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17899020%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17899020%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

303-312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17899020%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00213-007-0931-8

8 January 2020

exact match

0 references

cites work

Adenosine A(2A) receptor antagonist treatment of Parkinson's disease

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-007-0931-8

Partial dopamine agonist therapy of levodopa-induced dyskinesias

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-007-0931-8

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-007-0931-8

Deficits in Feeding Behavior after Intraventricular Injection of 6-Hydroxydopamine in Rats

21 January 2018

1 reference

12 December 2020

Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study).

1 reference

12 December 2020

Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test

1 reference

12 December 2020

Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain

1 reference

12 December 2020

Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations

1 reference

12 December 2020

Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine

1 reference

12 December 2020

Behavioral and anatomical effects of long-term L-dihydroxyphenylalanine (L-DOPA) administration in rats with unilateral lesions of the nigrostriatal system

1 reference

12 December 2020

Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model.

1 reference

12 December 2020

The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments

1 reference

12 December 2020

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

1 reference

12 December 2020

Failure of the ubiquitin-proteasome system in Parkinson's disease

1 reference

12 December 2020

The Corridor Task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum.

1 reference

12 December 2020

Differentiation of dopamine agonists using drug-induced rotation in rats with unilateral or bilateral 6-hydroxydopamine destruction of ascending dopamine pathways.

1 reference

12 December 2020

Reproducible nigral cell loss after systemic proteasomal inhibitor administration to rats.

1 reference

12 December 2020

Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats

1 reference

12 December 2020

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

1 reference

12 December 2020

Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates.

1 reference

12 December 2020

Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey.

1 reference

12 December 2020

Repeated administration of the monoamine reuptake inhibitor BTS 74 398 induces ipsilateral circling in the 6-hydroxydopamine lesioned rat without sensitizing motor behaviours

1 reference

12 December 2020

Genetic mouse models of parkinsonism: strengths and limitations

1 reference

12 December 2020

Altered proteasomal function in sporadic Parkinson's disease

1 reference

12 December 2020

Proteasome inhibitor-induced model of Parkinson's disease

1 reference

12 December 2020

Entacapone enhances levodopa-induced reversal of motor disability in MPTP-treated common marmosets

1 reference

12 December 2020

Monoamines in the human neostriatum: Topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor

1 reference

12 December 2020

Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease

1 reference

12 December 2020

Reinstatement of eating by dopamine agonists in aphagic dopamine denervated rats

1 reference

12 December 2020

Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey

1 reference

12 December 2020

Animal models of Parkinson's disease.

1 reference

12 December 2020

Recent failures of new potential symptomatic treatments for Parkinson's disease: causes and solutions

1 reference

12 December 2020

Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.

1 reference

12 December 2020

Beginning-of-dose and rebound worsening in MPTP-treated common marmosets treated with levodopa

1 reference

12 December 2020

Proteasomal function is impaired in substantia nigra in Parkinson's disease

1 reference

12 December 2020

The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates

1 reference

12 December 2020

The neurochemical and clinical effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in small animals.

1 reference

12 December 2020

Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system.

1 reference

12 December 2020

Brasofensine treatment for Parkinson's disease in combination with levodopa/carbidopa

1 reference

12 December 2020

Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants

1 reference

12 December 2020

Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease

1 reference

12 December 2020

L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats

1 reference

12 December 2020

The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy

1 reference

12 December 2020

Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration

1 reference

12 December 2020

Analysis of limb use by control rats and unilateral DA-depleted rats in the Montoya staircase test: movements, impairments and compensatory strategies.

1 reference

12 December 2020

Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction.

1 reference

12 December 2020

1 reference

12 December 2020

Lack of nigrostriatal pathology in a rat model of proteasome inhibition.

1 reference

12 December 2020

Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?

1 reference

12 December 2020

Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

1 reference

12 December 2020

Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra.

1 reference

12 December 2020

Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).

1 reference

12 December 2020

Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys.

1 reference

12 December 2020

Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys.

1 reference

12 December 2020

Mode and mechanism of action of neurotoxic indoleamines: a review and a progress report

1 reference

12 December 2020

Proteasome inhibition and Parkinson's disease modeling

1 reference

12 December 2020

Neglect of memory after dopaminergic lesions in monkeys

1 reference

12 December 2020

Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease.

1 reference

12 December 2020

Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial

1 reference

12 December 2020

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

1 reference

12 December 2020

Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.

1 reference

12 December 2020

A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets

1 reference

12 December 2020

Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: keys to success and roads to failure

1 reference

12 December 2020

Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons.

1 reference

12 December 2020

Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats

1 reference

12 December 2020

Protocol for the MPTP mouse model of Parkinson's disease

1 reference

12 December 2020

The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration

1 reference

12 December 2020

A Drosophila model of Parkinson's disease

1 reference

12 December 2020

Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus).

1 reference

12 December 2020

Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys.

1 reference

12 December 2020

Validation of the l-dopa-induced dyskinesia in the 6-OHDA model and evaluation of the effects of selective dopamine receptor agonists and antagonists

1 reference

12 December 2020

Behavioural effects of (+)-4-propyl-9-hydroxynaphthoxazine in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

12 December 2020

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

1 reference

12 December 2020

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

1 reference

12 December 2020

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

12 December 2020

Recovery of Feeding and Drinking by Rats after Intraventricular 6-Hydroxydopamine or Lateral Hypothalamic Lesions

1 reference

12 December 2020

Metabolic enzyme expression in dopaminergic neurons in Parkinson's disease: an in situ hybridization study

1 reference

12 December 2020

Circling behavior in rats with 6-hydroxydopamine or electrolytic nigral lesions,

1 reference

12 December 2020

Variable effects of chronic subcutaneous administration of rotenone on striatal histology

1 reference

12 December 2020

1 reference

12 December 2020

Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

1 reference

12 December 2020

Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration

1 reference

12 December 2020

Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys.

1 reference

12 December 2020

Rapid induction of serotonergic hyperinnervation in the adult rat striatum with extensive dopaminergic denervation

1 reference

12 December 2020

Activation-induced restoration of sensorimotor functions in rats with dopamine-depleting brain lesions

1 reference

12 December 2020

Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease

1 reference

12 December 2020

The rotenone model of parkinsonism--the five years inspection.

1 reference

12 December 2020

Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature

1 reference

12 December 2020

Rotenone induces non-specific central nervous system and systemic toxicity

1 reference

12 December 2020

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.

1 reference

12 December 2020

Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease

1 reference

12 December 2020